TOR Equity Snapshot
MDNA Weekly Equity Report
Medicenna Therapeutics Corp.
What the company does
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and …
What the weekly tape is saying
MDNA closed the latest completed week at 0.42 CAD. The 4-week return is -22.2% and the 12-week return is -40.0%. Trend Signal is inactive, Market Dynamics is -1.32. Setup signature: Risk-first tape with a 7/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.83 CAD
- Vs Trend Line
- -49.1%
- Fair Value
- 1.17 CAD
- Vs Fair Value
- -64.1%
- 52W High
- 1.97 CAD
- 52W Low
- 0.41 CAD
- Drawdown
- -78.7%
- Range Position
- 0.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 10
- 52W Active Breadth
- 19.2%
- Sector Scope
- CA Healthcare
- Sector Rank
- 40 of 46
- Sector Percentile
- 13.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
CA Healthcare
- Tracked Peers
- 46
- 4W Rank
- 46 of 46
- Avg 1W
- -0.5%
- Avg 4W
- -1.3%
- Trend Breadth
- 34.8%
- Positive MD
- 56.5%
CA Biotechnology
- Tracked Peers
- 12
- 4W Rank
- 12 of 12
- Avg 1W
- 0.1%
- Avg 4W
- -2.9%
- Trend Breadth
- 25.0%
- Positive RS
- 8.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.32
- 4W MD Change
- -85.0%
- Relative Strength
- -60.13
- 4W RS Change
- -20.1%
- Expectation
- Negative
- Probability
- 35.73%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 164.3K
- 13W Average
- 519.6K
- 52W Average
- 440.1K
- Vs 13W
- 0.3x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.2%
- 52W Volatility
- 14.1%
- Upside Weeks
- 15
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 12.4% / -6.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- TOR
- Country
- CA
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- CAD
- Market Cap
- 35.5M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.42 CAD | -6.7% | 0.83 CAD | 1.17 CAD | -1.32 | -60.13 | 164.3K | Off |
| 5 Jun 2026 | 0.45 CAD | 5.9% | 0.86 CAD | 1.17 CAD | -1.08 | -57.23 | 564.3K | Off |
| 29 May 2026 | 0.42 CAD | -6.6% | 0.89 CAD | 1.17 CAD | -0.95 | -60.55 | 458.9K | Off |
| 22 May 2026 | 0.46 CAD | -15.7% | 0.93 CAD | 1.18 CAD | -0.80 | -58.03 | 830.6K | Off |
| 15 May 2026 | 0.54 CAD | -14.3% | 0.96 CAD | 1.18 CAD | -0.72 | -50.07 | 979.5K | Off |
| 8 May 2026 | 0.63 CAD | 3.3% | 0.98 CAD | 1.18 CAD | -0.86 | -43.11 | 246.7K | Off |
| 1 May 2026 | 0.61 CAD | -6.2% | 0.99 CAD | 1.18 CAD | -1.14 | -45.37 | 431.9K | Off |
| 24 Apr 2026 | 0.65 CAD | 6.6% | 1.00 CAD | 1.18 CAD | -1.38 | -42.61 | 827.5K | Off |
| 17 Apr 2026 | 0.61 CAD | -6.2% | 1.01 CAD | 1.19 CAD | -1.60 | -47.57 | 890.4K | Off |
| 10 Apr 2026 | 0.65 CAD | 4.8% | 1.02 CAD | 1.19 CAD | -1.72 | -43.94 | 185.8K | Off |
| 3 Apr 2026 | 0.62 CAD | -1.6% | 1.04 CAD | 1.19 CAD | -1.59 | -46.14 | 173.7K | Off |
| 27 Mar 2026 | 0.63 CAD | -10.0% | 1.05 CAD | 1.19 CAD | -1.35 | -43.93 | 595.1K | Off |
| 20 Mar 2026 | 0.70 CAD | -9.1% | 1.07 CAD | 1.19 CAD | -1.19 | -37.11 | 406.4K | Off |
| 13 Mar 2026 | 0.77 CAD | -6.1% | 1.08 CAD | 1.19 CAD | -1.04 | -34.05 | 642.5K | Off |